Literature DB >> 17071012

Chronic pain: a non-use disease.

L Pruimboom1, A C van Dam.   

Abstract

One of the major problems in modern medicine is to find remedies for the group of people with chronic pain syndromes. Low back pain is one of the most frequent syndromes and perhaps the most invalidating of all of them. Chronic pain seems to develop through several pathways affecting the spinal cord and the brain: (1) neuro-anatomical reorganisation, (2) neuro-physiological changes, and (3) activation of glia cells (immune reaction in the central nervous system). Although all of these pathways seem to provide a (partial) plausible explanation for chronic pain, treatments influencing these pathways often fail to alleviate chronic pain patients. This could be because of the probability that chronic pain develops by all three mechanisms of disease. A treatment influencing just one of these mechanisms can only be partially successful. Other factors that seem to contribute to the development of chronic pain are psychosocial. Fear, attention and anxiety are part of the chronic pain syndrome being cause or consequence. The three pathways and the psycho-emotional factors constitute a psycho-neuro-immunological substrate for chronic pain syndromes; a substrate which resembles the substrate for phantom pain and functional invalidity after stroke. Both phantom pain and functional invalidity are considered non-use syndromes. The similarity of the substrate of both these two neurological disorders and chronic pain makes it reasonable to consider chronic pain a non-use disease (the hypothesis). To test this hypothesis, we developed a "paradoxal pain therapy". A therapy which combines the constraint induced movement therapy and strategies to dissociate pain from conditioning factors like fear, anxiety and attention. The aim of the therapy is to establish a behaviour perpendicular on the pathological pain-behaviour. Clinically, the treatment seems promising, although we just have preliminary results. Further clinical and laboratory studies are needed to measure eventual changes at neuro-anatomical and neuro-psychological level using modern neuro-imaging instruments (PET, SPECT, fMRI). Randomised clinical trials should be carried out to test our hypothesis for all-day use in clinical practice. The hypothesis: chronic pain is a non-use disease produced by psycho-emotional factors like fear, attention and anxiety. Optimal treatment should be based on physiological use, and dissociation of pain and the mentioned psycho-emotional factors. Paradoxal pain therapy could serve these treatment conditions.

Entities:  

Mesh:

Year:  2006        PMID: 17071012     DOI: 10.1016/j.mehy.2006.08.036

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

1.  Cell based therapy for the management of chronic pain.

Authors:  Younghoon Jeon
Journal:  Korean J Anesthesiol       Date:  2011-01-28

2.  LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.

Authors:  Shouyu Wang; Hong Xu; Lifang Zou; Jinyang Xie; Hong Wu; Bing Wu; Zhihua Yi; Qiulan Lv; Xi Zhang; Mofeng Ying; Shuangmei Liu; Guilin Li; Yun Gao; Changshui Xu; Chunping Zhang; Yun Xue; Shangdong Liang
Journal:  Purinergic Signal       Date:  2015-12-19       Impact factor: 3.765

3.  lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia.

Authors:  Haiying Peng; Lifang Zou; Jinyan Xie; Hong Wu; Bing Wu; Gaochun Zhu; Qiulan Lv; Xi Zhang; Shuangmei Liu; Guilin Li; Hong Xu; Yun Gao; Changshui Xu; Chunping Zhang; Shouyu Wang; Yun Xue; Shangdong Liang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 4.  Pharmacology of intra-articular triamcinolone.

Authors:  Justin Scherer; K D Rainsford; Colin A Kean; Walter F Kean
Journal:  Inflammopharmacology       Date:  2014-05-14       Impact factor: 4.473

Review 5.  New concept for backache: biopsychosocial pain syndrome.

Authors:  Shinichi Kikuchi
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

6.  Why self-induced pain feels less painful than externally generated pain: distinct brain activation patterns in self- and externally generated pain.

Authors:  Yan Wang; Jin-Yan Wang; Fei Luo
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

7.  LncRNA NONRATT021972 Was Associated with Neuropathic Pain Scoring in Patients with Type 2 Diabetes.

Authors:  Wei Yu; Guo-Qing Zhao; Rang-Juan Cao; Zhi-Hua Zhu; Kai Li
Journal:  Behav Neurol       Date:  2017-08-08       Impact factor: 3.342

Review 8.  Bioactive Peptides: Synthesis, Sources, Applications, and Proposed Mechanisms of Action.

Authors:  Mohsen Akbarian; Ali Khani; Sara Eghbalpour; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

9.  The musculoskeletal abnormalities of the Similaun Iceman ("ÖTZI"): clues to chronic pain and possible treatments.

Authors:  Walter F Kean; Shannon Tocchio; Mary Kean; K D Rainsford
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.